Thrombophilia, hypofibrinolysis, and alveolar osteonecrosis of the jaws

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 81, Issue 5, 1996, Pages 557-566

  Glueck, Charles J ^a   McMahon, Robert E ^b   Bouquot, Jerry ^c   Stroop, Davis ^d   Tracy, Trent ^a   Wang, Ping ^a   Rabinovich, Brian ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b Maxillofacial Center for Diagnostics and Research   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A; PROTEIN C; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PROTEIN DISORDER; BONE MARROW; BONE NECROSIS; CHI SQUARE DISTRIBUTION; DISEASE PREDISPOSITION; DRUG ANTAGONISM; FACE PAIN; FEMALE; FIBRINOLYSIS; HUMAN; JAW; JAW DISEASE; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROTEIN C DEFICIENCY; THROMBOSIS; VASCULARIZATION;

ADULT; AGED; ALVEOLAR PROCESS; BLOOD PROTEIN DISORDERS; BONE MARROW; CHI-SQUARE DISTRIBUTION; DISEASE SUSCEPTIBILITY; FACIAL PAIN; FEMALE; FIBRINOLYSIS; HUMANS; JAW DISEASES; LIPOPROTEIN(A); MALE; MIDDLE AGED; OSTEONECROSIS; PROTEIN C; PROTEIN C DEFICIENCY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030141158     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(96)80047-3     Document Type: Article

References (39)

1. Glueck CJ, Freiber R, Glueck HI, et al. Hypofibrinolysis: a common, major cause of osteonecrosis. Am J Hematol 1994;45:156-66.
2. Glueck CJ, Glueck HI, Greenfield D, et al. Protein C and S deficiency, thrombophilia, and hypofibrinolysis 1994;35:383-8.
3. Glueck CJ, Crawford A, Roy D, Frelberg R, Glueck H, Stroop D. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg Am 1996;78:3-13.
4. Glueck CJ, Frelberg R, Glueck HI, Tracy T, Stroop D, Hamer T. Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein (a), and therapy with Stanozolol. Am J Hematol 1995;48:213-2.
5. Glueck CJ, Glueck HI, Mieczkowski L, Tracy T, Speirs J, Stroop D. Familial high plasminogen activator inhibitor with hypofibrinolysis: a new pathophysiologic cause of osteonecrosis? Thrombosis Haemostasis 1993;69:460-5.
6. Gruppo R, Glueck CJ, MaMahon RE, et al. Anticardiolipin antibodies and osteonecrosis of the jaws [abstract]. J Invest Med 1995;43:459.
7. Van Veldhuizen PJ, Neff J, Murphey MD, Bodensteiner D, Skikne BS. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am J Hematol 1993;44:243-8.
8. Jones JP. Intravascular coagulation and osteonecrosis. Clin Orthop 1992;277:41-54.
9. Bouquot JE, Roberts AM, Person P, Christian J. Neuralgiainducing cavitational osteonecrosis (NICO) osteomyelitis in 224 jawbone samples from patients with facial neuralgia. Oral Surg Oral Med Oral Pathol 1992;73:307-19.
10. Bouquot JE, Christian J. Long-term effects of jawbone curettage on the pain of facial neuralgia. J Oral Maxillofac Surg 1995;53:387-97.
11. Chang CC, Greenspan A, Gershwin ME. Osteonecrosis: current perspectives on pathogenesis and treatment. Semin Arthritis 1993;23:47-69.
12. Chuong R, Piper MA. Avascular necrosis of the mandibular condyle-pathogenesis and concepts of management. Oral Surg Oral Med Oral Pathol 1993;75:428-32.
13. Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and Ddimer. Metabolism 1993;42:236-46.
14. Glueck CJ, Glueck BI, Tracy T, Speirs J, McCray C, Stroop D. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia. Metabolism 1993;42:1410-9.
15. Rånby M, Norrman B, Wallén P. A sensitive assay for tissue plasminogen activator. Thromb Res 1982;27:743-9.
16. Rånby M, Sundell IB, Nilsson TK. Blood collection in strong acid citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb Haemost 1989;62:917-22.
17. Chmielewska J, Rånby M, Wiman B. Evidence for rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983;31:427-36.
18. Amiral J, Boyer C, Rothchild C, Wolf M. Determination of protein C by an immunoenzymatic assay. In: Witt I, ed. Protein C: biochemical and medical aspects. Berlin: Walter de Gruyter, 1983:67-9.
19. Amiral J, Adam M, Plassart V, Minard F, Vissac AM. Immunoassays for the measurement of protein S. In: Gaffney PJ, ed. Fibrinolysis: current prospects. London: John Libbey, 1988:125-8.
20. Sochynsky CL, Joyner KA, Ortel TI. Clinical note: a method for testing APC resistance in thrombotic patients. Am Clin Lab 1994;13:26-7.
21. Svensson PJ, Dahlback B. Resistance of activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-22.
22. Sndedcor GW, Cochran WG. Statistical methods. 7th ed. Ames, Iowa: Iowa State University Press, 1980:1-507.
23. Mankin Jt{. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 1992;326:1473-9.
24. Glueck CJ, Crawford A, Roy D, Freiberg R, Glueck H, Stroop D. Familial thrombophilia, hypofibrinolysis, and hiqh lipoprotein(a): pathophysiologic etiologies of Legg-Perthes disease [Abstract]. J Invest Med 1005;43(suppl2):233.
25. Glueck CJ, McMahon RE, Bouquot JE, et al. Resistance to activated protein C, estrogens, and osteonecrosis of the jaws [Abstract]. J Invest Med 1995;43(suppl2):234.
26. Barkhodar RA, Hussain MZ, Hayashi C, Detection of inter-leukin-1 beta in human periapical lesions. Oral Surg Oral Med Oral Pathol 1992;73:334-6.
27. Hargreaves KM, Troullos ES, Dionne RA, Schmidt EA, Schafer SC, Joris JL. Bradykinin is increased during acute and chronic inflammation: therapeutic implications. Clin Pharmacol Ther 1988;44:613-21.
28. Lerner UH. Regulation of bone metabolism by the kallikreinkinin system, the coagulation cascade, and the acute phase reactants. Oral Surg Oral Med Oral Pathol 1994;78:481-93.
29. Safavi KE, Rosscuendo EF. Tumor necrosis factor identified in periapical tissue exudates of teeth with apical periedontitis. J Endodon 1991;17:12-3.
30. Wannafors K. Vascular changes after experimentally induced inflammation in the mandible. Int J Oral Mxillofac Surg 1989;18:79-82.
31. Kawakami T, Nakamura C, Eda S. Effects of the penetration of a root canal filling material into the mandibular canal: 1. Tissue reaction to the material. 2. changes in the alveolar nerve tissue. Ended Dent Traumatol 1991;15:539-43.
32. 14C labelled formaldehyde applied in the root canal following pulpectomy. J Endodon 1989;15:539-43.
33. Spangberg LSW. N2, formaldehyde, and milk. Oral Surg Oral Med Oral Pathol 1994;77:551.
34. Dray A, Urban L, Dickenson A. Pharmacology of chronic pain. Trends Pharmacol 1994;15:190-7.
35. Dubher R. Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury. Proceedings of the 6th World Congress on Pain. In: Bond MR, Charlton JE, Woolf CJ, eds. Pain research and clinical management. Vol 4. Amsterdam, The Netherlands: Elsevier, 1991:263-76.
36. Sweet DE, Madewell JE. Osteonecrosis: pathogenesis. In: Resnick D, ed. Diagnosis of bone and joint disorders. 3rd ed. Philadelphia: WB Saunders, 1995:3445-9.
37. Fardy MJ, Patton DW. Complications associated with peripheral alcohol injections in the management of trigeminal neuralgia. Br J Oral Maxillofac Surg 1994;32:387-91.
38. Goodnight JW, Calcaterra T. Trigeminal trophic syndrome: a report of two cases and review. Am J Otol 1994;15:219-22.
39. Dunlap CL. Post-rhizotomy periodontal atrophy. J Periodontal 1995;66:301-2.